Generally, these discoveries demonstrated that NMN could be a promising drug for obese-associated and age-induced T2D through the role it plays in the enhancement of NAD+ biosynthesis and Sirt1 activity. The gene discussed is SIRT1; the disease is type 2 diabetes mellitus.